Sign in

First statin approved

1987Big moment

Lovastatin, building on Akira Endo's discovery of cholesterol-blocking compounds in fungi, is approved. Statins become among the most prescribed drugs in the world.

The story

On August 31, 1987, the U.S. Food and Drug Administration approved lovastatin, sold by Merck as Mevacor. It was the first statin, a class of drugs that lower cholesterol in the blood by blocking an enzyme, HMG-CoA reductase, that the liver uses to make it. Statins went on to become some of the most widely prescribed medicines in the world, taken by many millions of people to prevent heart attacks and strokes.

The story begins with the Framingham Heart Study, launched in 1948 in Massachusetts, which followed thousands of residents and showed that high cholesterol, along with high blood pressure and smoking, raised the risk of heart disease. Researchers were therefore keen to lower cholesterol, but the available drugs were weak or hard to tolerate. In 1973 the Japanese biochemist Akira Endo at the company Sankyo, working on the idea that fungi might produce chemicals to block cholesterol-making enzymes as a defense against competing microbes, screened thousands of fungal broths. He found mevastatin, also called compactin, in a mold related to Penicillium. Safety concerns in animal studies stopped its development, but it showed the approach worked. Merck's lab under Roy Vagelos isolated lovastatin from the mold Aspergillus terreus.

Whether lowering cholesterol actually saved lives had to be proved by large trials, and the first big one, the Scandinavian Simvastatin Survival Study published in 1994, showed that simvastatin cut deaths from heart disease and overall mortality in patients with heart disease. Later trials found benefits for many more people. Atorvastatin, sold as Lipitor from 1997, became the best-selling drug in history, with cumulative sales above 125 billion dollars. Statins lower LDL cholesterol by about a third or more and reduce cardiovascular events. Side effects such as muscle pain are real but, in the largest trials, uncommon for serious harm, and the overall benefit is judged to outweigh the risks for most people at high risk.

Why it mattered

  • Heart attack and stroke rates fell as statins became routine for people at high risk, contributing to the long decline in cardiovascular death in wealthy countries.
  • The success of Lipitor made it among the most profitable drugs ever and helped shape pharmaceutical business models.
  • Statins established the principle of preventive drug treatment for risk factors in people who feel healthy.
  • Medicines from fungi and other microbes were shown to be a rich source of new drugs.

Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made

Community notes

Loading notes…

Learn more ranked by votes

BookDaniel Steinberg
The Cholesterol Wars
Search Open Library
VideoSearch YouTube
history of statins Akira Endo
Search YouTube